BioStack
Platform building data infrastructure for medical AI by integrating fragmented clinical information.
BioStack is a healthtech company, founded in 2025. It has raised $9.5 million in disclosed funding. Its latest round was a Seed of $9.5 million in October 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $9.5M across 1 round. Computed only from sourced rounds.
Investors
Questions and answers
What does BioStack do?
Platform building data infrastructure for medical AI by integrating fragmented clinical information.
How much has BioStack raised?
BioStack has raised $9.5 million in disclosed funding across 1 round tracked by OSH.
Who has invested in BioStack?
Investors in BioStack include Peak XV Partners, Afore Capital, DCVC, Emerson Collective, SV Angel and 3 more.
When and where was BioStack founded?
BioStack was founded in 2025.
Timeline
Founded
Sources
- 1.BioStack Nets $9.5 Mn To Build Training Datasets For Medical AI — Inc42, Oct 26, 2026